Biotech

All Articles

Metsera partner with Amneal to secure down GLP-1 supply

.Along with early phase 1 information today out in the wild, metabolic disease ensemble Metsera is a...

Rivus articles information to support muscle-sparing being overweight medicine insurance claims

.Rivus Pharmaceuticals has revealed the records behind its period 2 obesity succeed in heart failure...

BMS pays $110M to form T-cell therapy contract, aiding Main purchase opportunity to improve prioritized pipeline

.Bristol Myers Squibb is paying Perfect Medication $110 million ahead of time to cultivate reagents ...

Generate increases an additional $1B-plus Huge Pharma collaboration

.Novartis has actually printer inked a package possibly worth more than $1 billion along with Flagsh...

Metsera GLP-1 records piece exposes 7.5% weight-loss at 36 days

.Recently debuted Metsera is actually unfolding some period 1 record for its own GLP-1 receptor agon...

Flagship wishes biotechs flock to Mirai to improve hereditary meds

.Among the hereditary medicines arms ethnicity, Flagship Pioneering is revealing a brand new company...

BioAge eyes $180M coming from IPO, exclusive positioning for obesity tests

.BioAge Labs is actually checking out about $180 million in first proceeds coming from an IPO as wel...

Merck's LAG-3 combo falls short intestines cancer cells phase 3 study

.An attempt through Merck &amp Co. to uncover the microsatellite steady (MSS) metastatic colon cance...

Spanish VC shuts $200M lifestyle scientific researches fund

.Spain-based Asabys Allies has actually finalized a fund of 180 million euros ($ 200 million), money...

BioAge generates $198M coming from IPO as obesity biotech signs up with Nasdaq

.BioAge Labs is actually introducing virtually $200 million through its own Nasdaq IPO today, with t...